Patents by Inventor Alaeddine DJILLANI

Alaeddine DJILLANI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptides derived from the propeptide NTSR3 and their use in the treatment of depression
    Patent number: 11220527
    Abstract: Disclosed are new peptides derived from the neurotensin receptor 3 (NTSR3), and to their use, particularly in the treatment of various diseases, especially depression.
    Type: Grant
    Filed: October 11, 2017
    Date of Patent: January 11, 2022
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITÉ DE NICE SOPHIA ANTIPOLIS
    Inventors: Jean Mazella, Marc Borsotto, Catherine Heurteaux, Alaeddine Djillani, Sébastien Moreno, Mariel Pietri
  • PEPTIDES DERIVED FROM THE PROPEPTIDE NTSR3 AND THEIR USE IN THE TREATMENT OF DEPRESSION
    Publication number: 20190270771
    Abstract: Disclosed are new peptides derived from the neurotensin receptor 3 (NTSR3), and to their use, particularly in the treatment of various diseases, especially depression.
    Type: Application
    Filed: October 11, 2017
    Publication date: September 5, 2019
    Inventors: Jean MAZELLA, Marc BORSOTTO, Catherine HEURTEAUX, Alaeddine DJILLANI, Sébastien MORENO, Mariel PIETRI